APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Nutraceutical

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Nutraceutical Market Analysis and Forecast 2026-2032

30 December 2025207 pages

Choose your research edition.

Industry ResearchOral Nutraceutical Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Nutraceutical Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Oral Nutraceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Nutraceutical Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Nutraceutical Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Oral Nutraceutical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Oral Nutraceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Nutraceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Nutraceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Nutraceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Oral Nutraceutical include DSM, Barilla Group, Freedom Food Group Limited, Glanbia, Hero Group, Kerry Group, Nature’s Bounty, Raisio Group and Archer Daniels Midland, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Oral Nutraceutical, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Nutraceutical, also provides the revenue of main regions and countries. Of the upcoming market potential for Oral Nutraceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Nutraceutical revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Nutraceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Oral Nutraceutical revenue, projected growth trends, production technology, application and end-user industry.

Oral Nutraceutical Segment by Company

DSM

Barilla Group

Freedom Food Group Limited

Glanbia

Hero Group

Kerry Group

Nature’s Bounty

Raisio Group

Archer Daniels Midland

Amway

BASF

DuPont

Fonterra

Kellogg's

Cargill

Conagra

Nestlé

Tate & Lyle

General Mills

Ingredion

Oral Nutraceutical Segment by Type

Oral Solid Dosage Forms

Oral Liquid Dosage Forms

Oral Nutraceutical Segment by Application

Home Use

Hospital Use

Oral Nutraceutical Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Nutraceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Nutraceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Nutraceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Oral Nutraceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Oral Nutraceutical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Nutraceutical revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Nutraceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Solid Dosage Forms Major Player Table 3. Oral Liquid Dosage Forms Major Player Table 4. Global Oral Nutraceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Home Use Major Player Table 6. Hospital Use Major Player Table 7. Oral Nutraceutical Industry Trends Table 8. Oral Nutraceutical Industry Drivers Table 9. Oral Nutraceutical Industry Opportunities and Challenges Table 10. Oral Nutraceutical Industry Restraints Table 11. Global Oral Nutraceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Oral Nutraceutical Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Oral Nutraceutical Market Share by Region (2021-2026) Table 14. Global Oral Nutraceutical Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Oral Nutraceutical Market Share by Region (2027-2032) Table 16. Global Oral Nutraceutical Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Oral Nutraceutical Revenue Market Share by Players (2021-2026) Table 18. Global Oral Nutraceutical Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Oral Nutraceutical Key Players Headquarters & Area Served Table 20. Global Oral Nutraceutical Players, Product Type & Application Table 21. Global Oral Nutraceutical Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Oral Nutraceutical by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Oral Nutraceutical Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Oral Nutraceutical Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Oral Nutraceutical Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Oral Nutraceutical Revenue Market Share by Type (2021-2026) Table 28. Global Oral Nutraceutical Revenue Market Share by Type (2027-2032) Table 29. Global Oral Nutraceutical Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Oral Nutraceutical Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Oral Nutraceutical Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Oral Nutraceutical Revenue Market Share by Application (2021-2026) Table 33. Global Oral Nutraceutical Revenue Market Share by Application (2027-2032) Table 34. DSM Company Information Table 35. DSM Business Overview Table 36. DSM Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. DSM Oral Nutraceutical Product Portfolio Table 38. DSM Recent Development Table 39. Barilla Group Company Information Table 40. Barilla Group Business Overview Table 41. Barilla Group Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Barilla Group Oral Nutraceutical Product Portfolio Table 43. Barilla Group Recent Development Table 44. Freedom Food Group Limited Company Information Table 45. Freedom Food Group Limited Business Overview Table 46. Freedom Food Group Limited Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Freedom Food Group Limited Oral Nutraceutical Product Portfolio Table 48. Freedom Food Group Limited Recent Development Table 49. Glanbia Company Information Table 50. Glanbia Business Overview Table 51. Glanbia Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Glanbia Oral Nutraceutical Product Portfolio Table 53. Glanbia Recent Development Table 54. Hero Group Company Information Table 55. Hero Group Business Overview Table 56. Hero Group Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Hero Group Oral Nutraceutical Product Portfolio Table 58. Hero Group Recent Development Table 59. Kerry Group Company Information Table 60. Kerry Group Business Overview Table 61. Kerry Group Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Kerry Group Oral Nutraceutical Product Portfolio Table 63. Kerry Group Recent Development Table 64. Nature’s Bounty Company Information Table 65. Nature’s Bounty Business Overview Table 66. Nature’s Bounty Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Nature’s Bounty Oral Nutraceutical Product Portfolio Table 68. Nature’s Bounty Recent Development Table 69. Raisio Group Company Information Table 70. Raisio Group Business Overview Table 71. Raisio Group Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Raisio Group Oral Nutraceutical Product Portfolio Table 73. Raisio Group Recent Development Table 74. Archer Daniels Midland Company Information Table 75. Archer Daniels Midland Business Overview Table 76. Archer Daniels Midland Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Archer Daniels Midland Oral Nutraceutical Product Portfolio Table 78. Archer Daniels Midland Recent Development Table 79. Amway Company Information Table 80. Amway Business Overview Table 81. Amway Oral Nutraceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Amway Oral Nutraceutical Product Portfolio Table 83. Amway Recent Development Table 84. BASF Company Information Table 85. BASF Business Overview Table 86. BASF Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. BASF Oral Nutraceutical Product Portfolio Table 88. BASF Recent Development Table 89. DuPont Company Information Table 90. DuPont Business Overview Table 91. DuPont Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. DuPont Oral Nutraceutical Product Portfolio Table 93. DuPont Recent Development Table 94. Fonterra Company Information Table 95. Fonterra Business Overview Table 96. Fonterra Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Fonterra Oral Nutraceutical Product Portfolio Table 98. Fonterra Recent Development Table 99. Kellogg's Company Information Table 100. Kellogg's Business Overview Table 101. Kellogg's Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Kellogg's Oral Nutraceutical Product Portfolio Table 103. Kellogg's Recent Development Table 104. Cargill Company Information Table 105. Cargill Business Overview Table 106. Cargill Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Cargill Oral Nutraceutical Product Portfolio Table 108. Cargill Recent Development Table 109. Conagra Company Information Table 110. Conagra Business Overview Table 111. Conagra Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Conagra Oral Nutraceutical Product Portfolio Table 113. Conagra Recent Development Table 114. Nestlé Company Information Table 115. Nestlé Business Overview Table 116. Nestlé Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Nestlé Oral Nutraceutical Product Portfolio Table 118. Nestlé Recent Development Table 119. Tate & Lyle Company Information Table 120. Tate & Lyle Business Overview Table 121. Tate & Lyle Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Tate & Lyle Oral Nutraceutical Product Portfolio Table 123. Tate & Lyle Recent Development Table 124. General Mills Company Information Table 125. General Mills Business Overview Table 126. General Mills Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. General Mills Oral Nutraceutical Product Portfolio Table 128. General Mills Recent Development Table 129. Ingredion Company Information Table 130. Ingredion Business Overview Table 131. Ingredion Oral Nutraceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Ingredion Oral Nutraceutical Product Portfolio Table 133. Ingredion Recent Development Table 134. North America Oral Nutraceutical Revenue by Type (2021-2026) & (US$ Million) Table 135. North America Oral Nutraceutical Revenue by Type (2027-2032) & (US$ Million) Table 136. North America Oral Nutraceutical Revenue by Application (2021-2026) & (US$ Million) Table 137. North America Oral Nutraceutical Revenue by Application (2027-2032) & (US$ Million) Table 138. North America Oral Nutraceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. North America Oral Nutraceutical Revenue by Country (2021-2026) & (US$ Million) Table 140. North America Oral Nutraceutical Revenue by Country (US$ Million) & (2027-2032) Table 141. Europe Oral Nutraceutical Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Oral Nutraceutical Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Oral Nutraceutical Revenue by Application (2021-2026) & (US$ Million) Table 144. Europe Oral Nutraceutical Revenue by Application (2027-2032) & (US$ Million) Table 145. Europe Oral Nutraceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Europe Oral Nutraceutical Revenue by Country (2021-2026) & (US$ Million) Table 147. Europe Oral Nutraceutical Revenue by Country (US$ Million) & (2027-2032) Table 148. China Oral Nutraceutical Revenue by Type (2021-2026) & (US$ Million) Table 149. China Oral Nutraceutical Revenue by Type (2027-2032) & (US$ Million) Table 150. China Oral Nutraceutical Revenue by Application (2021-2026) & (US$ Million) Table 151. China Oral Nutraceutical Revenue by Application (2027-2032) & (US$ Million) Table 152. Asia Oral Nutraceutical Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Oral Nutraceutical Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Oral Nutraceutical Revenue by Application (2021-2026) & (US$ Million) Table 155. Asia Oral Nutraceutical Revenue by Application (2027-2032) & (US$ Million) Table 156. Asia Oral Nutraceutical Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 157. Asia Oral Nutraceutical Revenue by Region (US$ Million) & (2021-2026) Table 158. Asia Oral Nutraceutical Revenue by Region (US$ Million) & (2027-2032) Table 159. SAMEA Oral Nutraceutical Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Oral Nutraceutical Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Oral Nutraceutical Revenue by Application (2021-2026) & (US$ Million) Table 162. SAMEA Oral Nutraceutical Revenue by Application (2027-2032) & (US$ Million) Table 163. SAMEA Oral Nutraceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. SAMEA Oral Nutraceutical Revenue by Country (2021-2026) & (US$ Million) Table 165. SAMEA Oral Nutraceutical Revenue by Country (US$ Million) & (2027-2032) Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Oral Nutraceutical Image Figure 2. Global Oral Nutraceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Nutraceutical Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Solid Dosage Forms Image Figure 5. Oral Liquid Dosage Forms Image Figure 6. Global Oral Nutraceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Oral Nutraceutical Market Size Share 2021 VS 2025 VS 2032 Figure 8. Home Use Image Figure 9. Hospital Use Image Figure 10. Global Oral Nutraceutical Market Size (US$ Million) & (2021-2032) Figure 11. Global Oral Nutraceutical Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Oral Nutraceutical Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Oral Nutraceutical Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Oral Nutraceutical Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Oral Nutraceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Oral Nutraceutical Revenue Market Share by Type (2021-2032) Figure 18. Global Oral Nutraceutical Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Oral Nutraceutical Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Oral Nutraceutical Revenue Market Share by Application (2021-2032) Figure 21. North America Oral Nutraceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Oral Nutraceutical Revenue Share by Type (2021-2032) Figure 23. North America Oral Nutraceutical Revenue Share by Application (2021-2032) Figure 24. North America Oral Nutraceutical Revenue Share by Country (2021-2032) Figure 25. United States Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Oral Nutraceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Oral Nutraceutical Revenue Share by Type (2021-2032) Figure 30. Europe Oral Nutraceutical Revenue Share by Application (2021-2032) Figure 31. Europe Oral Nutraceutical Revenue Share by Country (2021-2032) Figure 32. Germany Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Oral Nutraceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Oral Nutraceutical Revenue Share by Type (2021-2032) Figure 42. China Oral Nutraceutical Revenue Share by Application (2021-2032) Figure 43. Asia Oral Nutraceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Oral Nutraceutical Revenue Share by Type (2021-2032) Figure 45. Asia Oral Nutraceutical Revenue Share by Application (2021-2032) Figure 46. Asia Oral Nutraceutical Revenue Share by Region (2021-2032) Figure 47. Japan Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Oral Nutraceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Oral Nutraceutical Revenue Share by Type (2021-2032) Figure 55. SAMEA Oral Nutraceutical Revenue Share by Application (2021-2032) Figure 56. SAMEA Oral Nutraceutical Revenue Share by Country (2021-2032) Figure 57. Brazil Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Oral Nutraceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solid Dosage Forms
  • Oral Liquid Dosage Forms
Applications
  • Home Use
  • Hospital Use
Companies covered
  • DSM
  • Barilla Group
  • Freedom Food Group Limited
  • Glanbia
  • Hero Group
  • Kerry Group
  • Nature’s Bounty
  • Raisio Group
  • Archer Daniels Midland
  • Amway
  • BASF
  • DuPont
  • Fonterra
  • Kellogg's
  • Cargill
  • Conagra
  • Nestlé
  • Tate & Lyle
  • General Mills
  • Ingredion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Nutraceutical Market by Type
  3. 1.2.1 Global Oral Nutraceutical Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Solid Dosage Forms
  5. 1.2.3 Oral Liquid Dosage Forms
  6. 1.3 Oral Nutraceutical Market by Application
  7. 1.3.1 Global Oral Nutraceutical Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Home Use
  9. 1.3.3 Hospital Use
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Oral Nutraceutical Market Dynamics
  1. 2.1 Oral Nutraceutical Industry Trends
  2. 2.2 Oral Nutraceutical Industry Drivers
  3. 2.3 Oral Nutraceutical Industry Opportunities and Challenges
  4. 2.4 Oral Nutraceutical Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Oral Nutraceutical Market Perspective (2021-2032)
  2. 3.2 Global Oral Nutraceutical Growth Trends by Region
  3. 3.2.1 Global Oral Nutraceutical Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Nutraceutical Market Size by Region (2021-2026)
  5. 3.2.3 Global Oral Nutraceutical Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Oral Nutraceutical Revenue by Players
  2. 4.1.1 Global Oral Nutraceutical Revenue by Players (2021-2026)
  3. 4.1.2 Global Oral Nutraceutical Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Oral Nutraceutical Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Nutraceutical Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Oral Nutraceutical Key Players Headquarters & Area Served
  7. 4.4 Global Oral Nutraceutical Players, Product Type & Application
  8. 4.5 Global Oral Nutraceutical Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Oral Nutraceutical Market CR5 and HHI
  11. 4.6.3 2025 Oral Nutraceutical Tier 1, Tier 2, and Tier 3
5 Oral Nutraceutical Market Size by Type
  1. 5.1 Global Oral Nutraceutical Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Oral Nutraceutical Revenue by Type (2021-2032)
  3. 5.3 Global Oral Nutraceutical Revenue Market Share by Type (2021-2032)
6 Oral Nutraceutical Market Size by Application
  1. 6.1 Global Oral Nutraceutical Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Oral Nutraceutical Revenue by Application (2021-2032)
  3. 6.3 Global Oral Nutraceutical Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 DSM
  2. 7.1.1 DSM Company Information
  3. 7.1.2 DSM Business Overview
  4. 7.1.3 DSM Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  5. 7.1.4 DSM Oral Nutraceutical Product Portfolio
  6. 7.1.5 DSM Recent Developments
  7. 7.2 Barilla Group
  8. 7.2.1 Barilla Group Company Information
  9. 7.2.2 Barilla Group Business Overview
  10. 7.2.3 Barilla Group Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Barilla Group Oral Nutraceutical Product Portfolio
  12. 7.2.5 Barilla Group Recent Developments
  13. 7.3 Freedom Food Group Limited
  14. 7.3.1 Freedom Food Group Limited Company Information
  15. 7.3.2 Freedom Food Group Limited Business Overview
  16. 7.3.3 Freedom Food Group Limited Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Freedom Food Group Limited Oral Nutraceutical Product Portfolio
  18. 7.3.5 Freedom Food Group Limited Recent Developments
  19. 7.4 Glanbia
  20. 7.4.1 Glanbia Company Information
  21. 7.4.2 Glanbia Business Overview
  22. 7.4.3 Glanbia Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Glanbia Oral Nutraceutical Product Portfolio
  24. 7.4.5 Glanbia Recent Developments
  25. 7.5 Hero Group
  26. 7.5.1 Hero Group Company Information
  27. 7.5.2 Hero Group Business Overview
  28. 7.5.3 Hero Group Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hero Group Oral Nutraceutical Product Portfolio
  30. 7.5.5 Hero Group Recent Developments
  31. 7.6 Kerry Group
  32. 7.6.1 Kerry Group Company Information
  33. 7.6.2 Kerry Group Business Overview
  34. 7.6.3 Kerry Group Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Kerry Group Oral Nutraceutical Product Portfolio
  36. 7.6.5 Kerry Group Recent Developments
  37. 7.7 Nature’s Bounty
  38. 7.7.1 Nature’s Bounty Company Information
  39. 7.7.2 Nature’s Bounty Business Overview
  40. 7.7.3 Nature’s Bounty Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Nature’s Bounty Oral Nutraceutical Product Portfolio
  42. 7.7.5 Nature’s Bounty Recent Developments
  43. 7.8 Raisio Group
  44. 7.8.1 Raisio Group Company Information
  45. 7.8.2 Raisio Group Business Overview
  46. 7.8.3 Raisio Group Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Raisio Group Oral Nutraceutical Product Portfolio
  48. 7.8.5 Raisio Group Recent Developments
  49. 7.9 Archer Daniels Midland
  50. 7.9.1 Archer Daniels Midland Company Information
  51. 7.9.2 Archer Daniels Midland Business Overview
  52. 7.9.3 Archer Daniels Midland Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Archer Daniels Midland Oral Nutraceutical Product Portfolio
  54. 7.9.5 Archer Daniels Midland Recent Developments
  55. 7.10 Amway
  56. 7.10.1 Amway Company Information
  57. 7.10.2 Amway Business Overview
  58. 7.10.3 Amway Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Amway Oral Nutraceutical Product Portfolio
  60. 7.10.5 Amway Recent Developments
  61. 7.11 BASF
  62. 7.11.1 BASF Company Information
  63. 7.11.2 BASF Business Overview
  64. 7.11.3 BASF Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  65. 7.11.4 BASF Oral Nutraceutical Product Portfolio
  66. 7.11.5 BASF Recent Developments
  67. 7.12 DuPont
  68. 7.12.1 DuPont Company Information
  69. 7.12.2 DuPont Business Overview
  70. 7.12.3 DuPont Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  71. 7.12.4 DuPont Oral Nutraceutical Product Portfolio
  72. 7.12.5 DuPont Recent Developments
  73. 7.13 Fonterra
  74. 7.13.1 Fonterra Company Information
  75. 7.13.2 Fonterra Business Overview
  76. 7.13.3 Fonterra Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Fonterra Oral Nutraceutical Product Portfolio
  78. 7.13.5 Fonterra Recent Developments
  79. 7.14 Kellogg's
  80. 7.14.1 Kellogg's Company Information
  81. 7.14.2 Kellogg's Business Overview
  82. 7.14.3 Kellogg's Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Kellogg's Oral Nutraceutical Product Portfolio
  84. 7.14.5 Kellogg's Recent Developments
  85. 7.15 Cargill
  86. 7.15.1 Cargill Company Information
  87. 7.15.2 Cargill Business Overview
  88. 7.15.3 Cargill Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Cargill Oral Nutraceutical Product Portfolio
  90. 7.15.5 Cargill Recent Developments
  91. 7.16 Conagra
  92. 7.16.1 Conagra Company Information
  93. 7.16.2 Conagra Business Overview
  94. 7.16.3 Conagra Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Conagra Oral Nutraceutical Product Portfolio
  96. 7.16.5 Conagra Recent Developments
  97. 7.17 Nestlé
  98. 7.17.1 Nestlé Company Information
  99. 7.17.2 Nestlé Business Overview
  100. 7.17.3 Nestlé Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Nestlé Oral Nutraceutical Product Portfolio
  102. 7.17.5 Nestlé Recent Developments
  103. 7.18 Tate & Lyle
  104. 7.18.1 Tate & Lyle Company Information
  105. 7.18.2 Tate & Lyle Business Overview
  106. 7.18.3 Tate & Lyle Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Tate & Lyle Oral Nutraceutical Product Portfolio
  108. 7.18.5 Tate & Lyle Recent Developments
  109. 7.19 General Mills
  110. 7.19.1 General Mills Company Information
  111. 7.19.2 General Mills Business Overview
  112. 7.19.3 General Mills Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  113. 7.19.4 General Mills Oral Nutraceutical Product Portfolio
  114. 7.19.5 General Mills Recent Developments
  115. 7.20 Ingredion
  116. 7.20.1 Ingredion Company Information
  117. 7.20.2 Ingredion Business Overview
  118. 7.20.3 Ingredion Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Ingredion Oral Nutraceutical Product Portfolio
  120. 7.20.5 Ingredion Recent Developments
8 North America
  1. 8.1 North America Oral Nutraceutical Revenue (2021-2032)
  2. 8.2 North America Oral Nutraceutical Revenue by Type (2021-2032)
  3. 8.2.1 North America Oral Nutraceutical Revenue by Type (2021-2026)
  4. 8.2.2 North America Oral Nutraceutical Revenue by Type (2027-2032)
  5. 8.3 North America Oral Nutraceutical Revenue Share by Type (2021-2032)
  6. 8.4 North America Oral Nutraceutical Revenue by Application (2021-2032)
  7. 8.4.1 North America Oral Nutraceutical Revenue by Application (2021-2026)
  8. 8.4.2 North America Oral Nutraceutical Revenue by Application (2027-2032)
  9. 8.5 North America Oral Nutraceutical Revenue Share by Application (2021-2032)
  10. 8.6 North America Oral Nutraceutical Revenue by Country
  11. 8.6.1 North America Oral Nutraceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Oral Nutraceutical Revenue by Country (2021-2026)
  13. 8.6.3 North America Oral Nutraceutical Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Oral Nutraceutical Revenue (2021-2032)
  2. 9.2 Europe Oral Nutraceutical Revenue by Type (2021-2032)
  3. 9.2.1 Europe Oral Nutraceutical Revenue by Type (2021-2026)
  4. 9.2.2 Europe Oral Nutraceutical Revenue by Type (2027-2032)
  5. 9.3 Europe Oral Nutraceutical Revenue Share by Type (2021-2032)
  6. 9.4 Europe Oral Nutraceutical Revenue by Application (2021-2032)
  7. 9.4.1 Europe Oral Nutraceutical Revenue by Application (2021-2026)
  8. 9.4.2 Europe Oral Nutraceutical Revenue by Application (2027-2032)
  9. 9.5 Europe Oral Nutraceutical Revenue Share by Application (2021-2032)
  10. 9.6 Europe Oral Nutraceutical Revenue by Country
  11. 9.6.1 Europe Oral Nutraceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Oral Nutraceutical Revenue by Country (2021-2026)
  13. 9.6.3 Europe Oral Nutraceutical Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Oral Nutraceutical Revenue (2021-2032)
  2. 10.2 China Oral Nutraceutical Revenue by Type (2021-2032)
  3. 10.2.1 China Oral Nutraceutical Revenue by Type (2021-2026)
  4. 10.2.2 China Oral Nutraceutical Revenue by Type (2027-2032)
  5. 10.3 China Oral Nutraceutical Revenue Share by Type (2021-2032)
  6. 10.4 China Oral Nutraceutical Revenue by Application (2021-2032)
  7. 10.4.1 China Oral Nutraceutical Revenue by Application (2021-2026)
  8. 10.4.2 China Oral Nutraceutical Revenue by Application (2027-2032)
  9. 10.5 China Oral Nutraceutical Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Nutraceutical Revenue (2021-2032)
  2. 11.2 Asia Oral Nutraceutical Revenue by Type (2021-2032)
  3. 11.2.1 Asia Oral Nutraceutical Revenue by Type (2021-2026)
  4. 11.2.2 Asia Oral Nutraceutical Revenue by Type (2027-2032)
  5. 11.3 Asia Oral Nutraceutical Revenue Share by Type (2021-2032)
  6. 11.4 Asia Oral Nutraceutical Revenue by Application (2021-2032)
  7. 11.4.1 Asia Oral Nutraceutical Revenue by Application (2021-2026)
  8. 11.4.2 Asia Oral Nutraceutical Revenue by Application (2027-2032)
  9. 11.5 Asia Oral Nutraceutical Revenue Share by Application (2021-2032)
  10. 11.6 Asia Oral Nutraceutical Revenue by Country
  11. 11.6.1 Asia Oral Nutraceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Oral Nutraceutical Revenue by Country (2021-2026)
  13. 11.6.3 Asia Oral Nutraceutical Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Nutraceutical Revenue (2021-2032)
  2. 12.2 SAMEA Oral Nutraceutical Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Oral Nutraceutical Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Oral Nutraceutical Revenue by Type (2027-2032)
  5. 12.3 SAMEA Oral Nutraceutical Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Oral Nutraceutical Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Oral Nutraceutical Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Oral Nutraceutical Revenue by Application (2027-2032)
  9. 12.5 SAMEA Oral Nutraceutical Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Oral Nutraceutical Revenue by Country
  11. 12.6.1 SAMEA Oral Nutraceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Oral Nutraceutical Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Oral Nutraceutical Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst